Merci Registry - Real World Use of the Merci Retrieval System in Acute Ischemic Stroke
NCT ID: NCT00478478
Last Updated: 2014-11-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1000 participants
OBSERVATIONAL
2007-06-30
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Post-procedure revascularization success
* 90-day mRS 0-2
* 90-day mortality
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The registry requires use (at least one pass in the intracranial vasculature) of any Merci Retriever device (X Series, L Series, V Series) in the setting of acute ischemic stroke due to large vessel intracranial occlusion.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acute Ischemic Stroke patients
Patients presenting with signs and symptoms consistent with a diagnosis of Acute Ischemic Stroke, who are treated with the Merci Retrieval System during a Mechanical Thrombectomy procedure.
Mechanical Thrombectomy
Thrombectomy performed with the Merci Retriever in the setting of acute ischemic stroke.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mechanical Thrombectomy
Thrombectomy performed with the Merci Retriever in the setting of acute ischemic stroke.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient/patient's surrogate provides informed consent and is willing to comply with the protocol requirements and complete required clinical evaluations, or in the absence of informed consent, an IRB/EC approved waiver of consent and executed data use agreement are in place
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stryker Neurovascular
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wade S Smith, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of California at San Francisco, SF, CA
Marilyn M Rymer, MD
Role: PRINCIPAL_INVESTIGATOR
MABSI St. Luke's, Kansas City, MO
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Luke's Brain and Stroke Institute
Kansas City, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Stryker Neurovascular
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INT-REG-001
Identifier Type: -
Identifier Source: org_study_id